OQROGet OQRO Pro
Insider trade

Kymera Therapeutics (KYMR)Director sold ~$311K

Jeffrey W. Albers, Director at Kymera Therapeutics, sold ~$311K of Kymera Therapeutics shares.

~$311K
Approx. value · 6,349 sh @ $49.00
Traded
Jun 3, 2025
Filed
Jun 3, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 23, 2025InsiderOfficer sold ~$75K of KYMR shares in the open market
  2. Jun 3, 2025 · this disclosureInsiderDirector sold ~$311K of KYMR shares in the open market

What came next

  1. Jun 3, 2025Insider · 3 peopleInsiders: 4 sales (~$2.3M)
  2. Jun 11, 2025InsiderDirector sold ~$225K of KYMR shares in the open market
  3. Jun 30, 2025Insider · 2 peopleInsiders: 5 purchases (~$42.8M)
  4. Sep 16, 2025InsiderCEO sold ~$1.47M of KYMR shares in the open market
  5. Sep 17, 2025Insider · Their largest sale since 2021CFO sold ~$3.96M of KYMR shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Kymera Therapeutics

For Kymera Therapeutics, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KYMR page.

Other recent filings by Jeffrey W. Albers, Director

The full history of Jeffrey W. Albers, Director is on the profile page.

How this filing works

Other disclosures at Kymera Therapeutics

Everything OQRO holds on this company is on its KYMR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data